Human Papillomavirus now causes many head and neck cancers, not only cervical cancer. Certain high-risk HPV strains persist ...

High human papillomavirus vaccination coverage may substantially reduce mortality due to cervical cancer, a population-based ...

Human papillomavirus (HPV) vaccination is already saving lives in the UK—and the scale of that success is striking.

Human papillomavirus (HPV) is necessary for the development of cervical carcinoma, and incorporation of molecular testing for HPV in screening and patient management has been proposed. Sufficient ...

Human papillomavirus (HPV) is now established as the principal cause of an increase in incidence of a subset of head and neck squamous cell cancers (HNCs) in numerous geographic regions around the ...

The anticipated licensure within the next three months of a vaccine against human papillomavirus (HPV) would represent a major public health advance against cervical cancer and other, less common ...

Human papillomavirus (HPV) is the most common sexually transmitted infectious agent; its 14 oncogenic types are causally associated with 5–10% of all cancers. The major structural HPV protein ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...